Highlights |
Jacobs School of Medicine & Biomedical Sciences at University at Buffalo: Concussion Treatment
Adolescent athletes who sustained concussions while playing a sport recovered more quickly when they underwent a supervised, aerobic exercise regimen, a study published Feb. 4 in JAMA Pediatrics has found. An editorial in the journal called it “a landmark study.” The study, by University at Buffalo researchers and colleagues, is the first randomized clinical trial of a treatment in the acute phase after a sport-related concussion. Take a closer look.
|
Albert Einstein College of Medicine: Brain’s Cerebellum Found to Influence Addictive and Social Behavior
In a study published online in the journal Science, researchers at Albert Einstein College of Medicine, part of Montefiore, prove for the first time that the brain’s cerebellum-long thought to be mainly involved in coordinating movement-helps control the brain’s reward circuitry. The surprising finding indicates that the cerebellum plays a major role in reward processing and social behaviors and could potentially lead to new strategies for treating addiction. Take a closer look.
|
Cancer |
Weill Cornell Medicine: Two Advances in Understanding Lymphomas May Lead to New Therapies
New studies from Weill Cornell Medicine researchers have revealed the importance of two gene-regulation proteins in the development of common immune cell cancers called lymphomas. The studies, published in Nature Immunology and in Cancer Discovery, showed that one of the proteins, LSD1, plays a major role in starting and sustaining lymphomas, while the other, TET2, normally prevents lymphomas from developing. Take a closer look.
|
New York Medical College : Dazhong Xu, Ph.D.; In Search of The Cure for Lung Cancer
Fascinated by the pervasive nature of cancer which affects the lives of so many, regardless of age, sex, or socioeconomic background, and equally interested in how environmental factors lead to carcinogenesis, Dazhong Xu, Ph.D., assistant professor of pathology at New York Medical College, says lung cancer research- which combines both his research interests- became the perfect arena in which he could make a difference. Take a closer look.
|
Columbia University Vagelos College of Physicians and Surgeons: Hepatitis is Common in New Cancer Patients
Many newly diagnosed cancer patients also are infected with hepatitis B or C virus-and are unaware of their viral status-a new study published in JAMA Oncology has found. Dawn L. Hershman, MD, MS, was a senior leader of the study, which was run by SWOG Cancer Research Network. Take a closer look.
|
Weill Cornell Medicine: Immunotherapy May Help Patients with Advanced Esophageal Cancer
Treating patients with advanced, metastatic esophageal cancer with an immune-system boosting drug called pembrolizumab, known by its brand name Keytruda, led to regression of tumors in some patients, according to results of a phase 2 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators. The results, though modest, may offer a new therapeutic approach for this population of patients for whom there are currently limited treatment options. Take a closer look.
|
Neurology |
Columbia University Vagelos College of Physicians and Surgeons: Aerobic Exercise Improves Cognition, Even in Young Adults
Aerobic exercise training improves cognition, even for young and middle-aged adults, according to a new study led by researchers at Columbia University Vagelos College of Physicians and Surgeons. The study of 132 adults between the ages of 20 and 67 found that aerobic exercise training increases executive function-cognitive processes important for reasoning, planning, and problem-solving-in adults as young as 20, although the effect was stronger with increasing age. Take a closer look.
|
Jacobs School of Medicine & Biomedical Sciences at University at Buffalo: Restoring Memory Function in Alzheimer’s Disease
Research published on January 22 in the journal Brain reveals a new approach to Alzheimer’s disease (AD) that may eventually make it possible to reverse memory loss, a hallmark of the disease in its late stages. The team, led by University at Buffalo scientists, found that by focusing on gene changes caused by influences other than DNA sequences – called epigenetics – it was possible to reverse memory decline in an animal model of AD. Take a closer look.
|
Genetics |
Icahn School of Medicine at Mount Sinai: Large-Scale Study Identifies Shared Genetic Architecture for Polycystic Ovary Syndrome Diagnosis
In the largest genetic analysis of polycystic ovary syndrome (PCOS) performed to date, an international consortium, including researchers at the Icahn School of Medicine at Mount Sinai, conducted a whole genome association study to identify common genetic architecture for different diagnostic criteria used to define the syndrome. The results are available online in the December 19 issue of the journal PLOS Genetics. Take a closer look.
|
Opioids |
NYU School of Medicine: Physician-Targeted Marketing Tied to Opioid Overdose Deaths
Many individuals cite prescription opioids as their gateway to illicit opioid use. Although prescription opioids are involved in more than one-third of all opioid overdose deaths in the United States, examining any correlation between prescription opioid overdose deaths and pharmaceutical industry marketing has been limited-until now. New research from NYU School of Medicine and Boston Medical Center published online on January 18 in JAMA Network Open shows that increased marketing of opioid products to physicians-from consulting fees to free meals-is associated with higher opioid prescribing rates and elevated overdose deaths in the United States. Take a closer look.
|
Infectious Disease |
New York Medical College: Fighting Influenza’s Deadly Reach
As many as 646,000 people succumb to the flu every year worldwide-yet that number would be much greater if not for Doris J. Bucher, Ph.D., associate professor of microbiology and immunology at New York Medical College (NYMC). In her laboratory in Valhalla, N.Y., Dr. Bucher and her associates are responsible for developing flu seed stock for the production of the world’s annual supply of influenza vaccine. Take a closer look.
|
NYU School of Medicine: New Way Proposed to Fight Staph Infections
A new class of engineered proteins may counter infection caused by Staphylococcus aureus-a bacterial species considered one of the largest global health threats, a new study suggests. Published online January 16 in Science Translational Medicine, the study is the result of a five-year research partnership between scientists at NYU School of Medicine and Janssen Research and Development, LLC (Janssen). Take a closer look.
|
Albert Einstein College of Medicine Responds to the Urgent Need for Effective Ebola Treatments
The current ebolavirus outbreak in central Africa’s Democratic Republic of the Congo (DRC) ranks as the second largest and second deadliest in history: more than 600 cases and more than 370 deaths as of January 6, according to the World Health Organization (WHO). Adding to the tragedy: children-who are much more likely to die from Ebola infection than adults-now account for more than one third of all cases. Take a closer look.
|
Diabetes |
SUNY Upstate Medical University: New Study Finds Benefits to Partner if Involved in Patient’s Plan to Manage Diabetes
A new study authored by an Upstate Medical University professor has found positive benefits for the partner of someone living with type 2 diabetes if the partner is involved in a program designed to help the patient manage their disease.
The study showed that when someone has type 2 diabetes, having the person’s partner involved in creating and maintaining a health plan can result in the partner feeling less distress about the patient’s disease and more satisfied with the overall relationship. Take a closer look.
|
Other Studies |
Icahn School of Medicine at Mount Sinai: NIH Funds First Artificial Pancreas Study in the United States for Pregnant Women
IThe National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials. The researchers hope that the first-in-the-nation studies will lead to a safe and effective at-home clinical trial with an extension phase to the end of pregnancy. Take a closer look.
|
New York Institute of Technology College of Osteopathic Medicine: Preventing eSports Injuries
ESports is redefining what it means to be a college athlete. While the NCAA explores whether to sanction eSports as an official “sport,” many institutions are already recognizing its legitimacy, with more than 80 U.S. colleges and universities already offering varsity eSport teams. Now the NYIT Center for eSports Medicine has published its first study, proving that eSports athletes face the risk of injuries just like any other athlete. Take a closer look.
|
Faculty News |
Weill Cornell Medicine: Dr. Barbara Hempstead Appointed Dean of the Weill Cornell Graduate School of Medical Sciences
Dr. Barbara Hempstead, a preeminent physician-scientist, educator and academic leader, has been appointed dean of the Weill Cornell Graduate School of Medical Sciences, effective Jan. 14. She succeeds Dr. Carl Nathan, who led the graduate school since 2017 and completed a planned two-year term. Take a closer look.
|
SUNY Upstate Medical University: Gregory P. Conners MD, MPH, MBA, Named Chair of Pediatrics at Upstate and Executive Director of Upstate Golisano Children’s Hospital
Gregory P. Conners, MD, MPH, MBA, associate chair of pediatrics at Children’s Mercy Hospitals & Clinic, University of Missouri, Kansas City School of Medicine, has been named chair of the Department of the Pediatrics at Upstate Medical University and executive director of Upstate Golisano Children’s Hospital. The appointment, effective March 4, was announced by Julio Licinio, MD, PhD, senior vice president for Academic Health Affairs and dean of the College of Medicine. Take a closer look.
|